Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

The purpose of this study was to investigate the effect of only local radical treatment of liver metastases combined with systematic treatment in the treatment of patients with multiple organ metastases of colorectal cancer, whether it can benefit the prognosis and explore the risk factors related to the prognosis.

Trial Details

NCT ID
NCT06449937
Phase
NA
Sponsor
Anhui Provincial Hospital
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • Radical local Surgery
  • Systemic therapy
  • Interventional therapy
Locations (sample)
  • Chuzhou, Anhui, China|32.32194,118.29778
  • Fuyang, Anhui, China|32.9,115.81667
  • Hefei, Anhui, China|31.86389,117.28083
  • Ma’anshan, Anhui, China|31.68579,118.51008
  • Wuhu, Anhui, China|31.35259,118.42947

Key Eligibility Criteria

  • Male or female, 18-80 years of age.
  • Patients volunteered to join the study and signed informed consent, with good compliance and follow-up.
  • Primary colorectal tumors can be radically resected or resected and histopathologically diagnosed as colorectal cancer.
  • Patients with synchronous or metachronous diagnosis of liver metastasis and extrahepatic metastasis by computed tomography (CT) or magnetic resonan…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →